A citation-based method for searching scientific literature

Esra Manguoğlu, Sefik Güran, Deniz Yamaç, Taner Colak, Mehmet Simşek, Mehmet Baykara, Mustafa Akaydın, Güven Lüleci. Cancer Genet Cytogenet 2010
Times Cited: 16







List of co-cited articles
114 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
H Yazici, O Bitisik, E Akisik, N Cabioglu, P Saip, M Muslumanoglu, G Glendon, E Bengisu, S Ozbilen, M Dincer,[...]. Br J Cancer 2000
40
37

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.
Z Kote-Jarai, D Leongamornlert, E Saunders, M Tymrakiewicz, E Castro, N Mahmud, M Guy, S Edwards, L O'Brien, E Sawyer,[...]. Br J Cancer 2011
250
31

Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients.
H Ozdag, M Tez, I Sayek, M Müslümanoglu, O Tarcan, F Içli, M Oztürk, T Ozçelik. Eur J Cancer 2000
21
31

BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients.
Gulsah Cecener, Unal Egeli, Berrin Tunca, Elif Erturk, Secil Ak, Sehsuvar Gokgoz, Ismet Tasdelen, Gulcin Tezcan, Elif Demirdogen, Nuran Bayram,[...]. Cancer Invest 2014
18
31

BRCA1 and BRCA2 have a limited role in familial prostate cancer.
C S Sinclair, R Berry, D Schaid, S N Thibodeau, F J Couch. Cancer Res 2000
53
25

Prostate cancer progression and survival in BRCA2 mutation carriers.
Laufey Tryggvadóttir, Linda Vidarsdóttir, Tryggvi Thorgeirsson, Jon Gunnlaugur Jonasson, Elinborg Jona Olafsdóttir, Gudridur Helga Olafsdóttir, Thorunn Rafnar, Steinunn Thorlacius, Eirikur Jonsson, Jorunn Erla Eyfjord,[...]. J Natl Cancer Inst 2007
154
25

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.
Stephen M Edwards, Zsofia Kote-Jarai, Julia Meitz, Rifat Hamoudi, Questa Hope, Peter Osin, Rachel Jackson, Christine Southgate, Rashmi Singh, Alison Falconer,[...]. Am J Hum Genet 2003
253
25

BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland.
T Ikonen, M P Matikainen, K Syrjäkoski, N Mononen, P A Koivisto, A Rökman, E H Seppälä, O-P Kallioniemi, T L J Tammela, J Schleutker. J Med Genet 2003
18
25

BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
Tomas Kirchhoff, Noah D Kauff, Nandita Mitra, Kedoudja Nafa, Helen Huang, Crystal Palmer, Tony Gulati, Eve Wadsworth, Sheri Donat, Mark E Robson,[...]. Clin Cancer Res 2004
110
25

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.
Ilir Agalliu, Robert Gern, Suzanne Leanza, Robert D Burk. Clin Cancer Res 2009
89
25

Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414del4 found in male breast cancer.
A Balci, P Huusko, K Pääkkönen, V Launonen, A Uner, A Ekmekçi, R Winqvist. Eur J Cancer 1999
19
25

Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
Unal Egeli, Gulsah Cecener, Berrin Tunca, Ismet Tasdelen. Cancer Invest 2006
16
25

BRCA1 and BRCA2: different roles in a common pathway of genome protection.
Rohini Roy, Jarin Chun, Simon N Powell. Nat Rev Cancer 2011
819
25

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
25

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
848
25

BRCA1 mutations and prostate cancer in Poland.
Cezary Cybulski, Bohdan Górski, Jacek Gronwald, Tomasz Huzarski, Tomasz Byrski, Tadeusz Debniak, Anna Jakubowska, Dominika Wokołorczyk, Bartłomiej Gliniewicz, Andrzej Sikorski,[...]. Eur J Cancer Prev 2008
31
18

High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.
G Johannesdottir, J Gudmundsson, J T Bergthorsson, A Arason, B A Agnarsson, G Eiriksdottir, O T Johannsson, A Borg, S Ingvarsson, D F Easton,[...]. Cancer Res 1996
180
18

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
18

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.
A Hubert, T Peretz, O Manor, L Kaduri, N Wienberg, I Lerer, M Sagi, D Abeliovich. Am J Hum Genet 1999
51
18

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
James D Fackenthal, Olufunmilayo I Olopade. Nat Rev Cancer 2007
301
18

Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.
Heather Thorne, Amber J Willems, Eveline Niedermayr, Ivan M Y Hoh, Jason Li, David Clouston, Gillian Mitchell, Stephen Fox, John L Hopper, Damien Bolton. Cancer Prev Res (Phila) 2011
81
18

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.
R M Giusti, J L Rutter, P H Duray, L S Freedman, M Konichezky, J Fisher-Fischbein, M H Greene, B Maslansky, A Fischbein, S B Gruber,[...]. J Med Genet 2003
65
18

Germline BRCA1 mutations increase prostate cancer risk.
D Leongamornlert, N Mahmud, M Tymrakiewicz, E Saunders, T Dadaev, E Castro, C Goh, K Govindasami, M Guy, L O'Brien,[...]. Br J Cancer 2012
188
18

BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data.
Laura Fachal, Antonio Gómez-Caamaño, Catuxa Celeiro-Muñoz, Paula Peleteiro, Ana Blanco, Ana Carballo, Jerónimo Forteza, Angel Carracedo, Ana Vega. Prostate 2011
16
18

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.
K L Nastiuk, M Mansukhani, M B Terry, P Kularatne, M A Rubin, J Melamed, M D Gammon, M Ittmann, J J Krolewski. Prostate 1999
51
18

No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer.
E P Wilkens, D Freije, J Xu, D R Nusskern, H Suzuki, S D Isaacs, K Wiley, P Bujnovsky, D A Meyers, P C Walsh,[...]. Prostate 1999
40
18

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece.
Chrissovaladis Koumpis, Constantine Dimitrakakis, Aris Antsaklis, Robert Royer, Shiyu Zhang, Steven A Narod, Joanne Kotsopoulos. Hered Cancer Clin Pract 2011
20
18


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
18


Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis.
Sefik Güran, Ahmet Ozet, Murat Dede, Johan J P Gille, Müfit Cemal Yenen. Cancer Genet Cytogenet 2005
9
33

Clinicopathologic characteristics and BRCA-1/BRCA-2 mutations of Turkish patients with breast cancer.
F Aydin, T Akagun, B Yildiz, E Fidan, F Ozdemir, H Kavgaci. Bratisl Lek Listy 2011
4
75

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy,[...]. J Clin Oncol 2013
444
18

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
18

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
David J Gallagher, Mia M Gaudet, Prodipto Pal, Tomas Kirchhoff, Lisa Balistreri, Kinjal Vora, Jasmine Bhatia, Zsofia Stadler, Samson W Fine, Victor Reuter,[...]. Clin Cancer Res 2010
192
18

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer.
M R Akbari, C J D Wallis, A Toi, J Trachtenberg, P Sun, S A Narod, R K Nam. Br J Cancer 2014
53
18

Subgroups of familial and aggressive prostate cancer with considerable frequencies of BRCA2 mutations.
Christiane Maier, Kathleen Herkommer, Manuel Luedeke, Antje Rinckleb, Mark Schrader, Walther Vogel. Prostate 2014
16
18

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Jacqueline Mersch, Michelle A Jackson, Minjeong Park, Denise Nebgen, Susan K Peterson, Claire Singletary, Banu K Arun, Jennifer K Litton. Cancer 2015
303
18

Genomic rearrangements in BRCA1 and BRCA2: A literature review.
Ingrid Petroni Ewald, Patricia Lisboa Izetti Ribeiro, Edenir Inêz Palmero, Silvia Liliana Cossio, Roberto Giugliani, Patricia Ashton-Prolla. Genet Mol Biol 2009
67
12

A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis.
Florence Coulet, Filipe Pires, Etienne Rouleau, Cedrick Lefol, Sabrina Martin, Chrystelle Colas, Odile Cohen-Haguenauer, Irina Giurgea, Anne Fajac, Catherine Noguès,[...]. Genet Test Mol Biomarkers 2010
16
12

BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
Jae Hong Seo, Dae-Yeon Cho, Se-Hyun Ahn, Kyung-Sik Yoon, Chang-Soo Kang, Hyun Mi Cho, Hyeon Sook Lee, Jae Jin Choe, Cheul Won Choi, Byung Soo Kim,[...]. Hum Mutat 2004
38
12

Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.
Ake Borg, Robert W Haile, Kathleen E Malone, Marinela Capanu, Ahn Diep, Therese Törngren, Sharon Teraoka, Colin B Begg, Duncan C Thomas, Patrick Concannon,[...]. Hum Mutat 2010
87
12

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
12

Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer.
S-H Han, K-R Lee, D-G Lee, B-Y Kim, K-E Lee, W-S Chung. Clin Genet 2006
43
12

Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990
12

Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.
E Thirthagiri, S Y Lee, P Kang, D S Lee, G T Toh, S Selamat, S-Y Yoon, N A Mohd Taib, M K Thong, C H Yip,[...]. Breast Cancer Res 2008
65
12


Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan.
S S Li, H M Tseng, T P Yang, C H Liu, S J Teng, H W Huang, L M Chen, H W Kao, J H Chen, J N Tseng,[...]. Hum Genet 1999
48
12

Global cancer statistics.
Ahmedin Jemal, Freddie Bray, Melissa M Center, Jacques Ferlay, Elizabeth Ward, David Forman. CA Cancer J Clin 2011
12

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype.
A Mitra, C Fisher, C S Foster, C Jameson, Y Barbachanno, J Bartlett, E Bancroft, R Doherty, Z Kote-Jarai, S Peock,[...]. Br J Cancer 2008
104
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.